Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.16 | 0.6 |
mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |